The HPV vaccine is a crucial public health intervention designed to prevent infections caused by the Human Papillomavirus. This common virus can lead to various...
The HPV vaccine protects against infections caused by the Human Papillomavirus (HPV), a common virus that can lead to certain cancers (e.g., cervical, anal, throat) and genital warts.
The vaccine is routinely recommended for adolescents aged 9-12 years. Catch-up vaccination is often advised for young adults up to age 26, and in some cases, up to age 45 after discussing with a healthcare provider.
Yes, extensive research and real-world data confirm the HPV vaccine is very safe and highly effective. It has significantly reduced HPV infections and precancerous lesions globally, with only minor, temporary side effects.
Individuals under 15 years typically require two doses over 6-12 months. Those 15 years and older usually need three doses over a six-month period for optimal protection.